QEFA news

SPDR MSCI EAFE StrategicFactors

Stories about this fund's companies, ranked by fund weight and recency. Times are local.

Quartz · 28 Oct 2026, 20:39 UTC
Consumer boycotts that worked: 9 that forced change
3.1% of QEFA
Bloomberg Business · 28 Oct 2026, 19:00 UTC
How's the US-China Tech War Going? Ask AI
2.5% of QEFA
Seeking Alpha · 28 Oct 2026, 15:21 UTC
SK hynix: Don't Panic Over The Immediate Threat Of CXMT's 4F Squared Efforts (NASDAQ:SKHY) | Seeking Alpha
2.5% of QEFA
Seeking Alpha · 28 Oct 2026, 18:55 UTC
Roche: Valuation Leaves Limited Upside (OTCMKTS:RHHBF) | Seeking Alpha
1.8% of QEFA
Where to buy QEFA
- [Broker A]Visit ↗
- [Broker B]Visit ↗
[Affiliate and risk wording from the law firm]
wallstreet:online · 28 Oct 2026, 14:05 UTC
Sandoz reports strong biosimilar-sales momentum; narrowed full-year net-sales range and upgrade to margin guidance
2.1% of QEFA
Seeking Alpha · 28 Oct 2026, 07:02 UTC
ASML: Exceptional Semiconductor Business, Expensive Valuation (NASDAQ:ASML) | Seeking Alpha
2.5% of QEFA
Where to buy QEFA
- [Broker A]Visit ↗
- [Broker B]Visit ↗
[Affiliate and risk wording from the law firm]
Seeking Alpha · 28 Oct 2026, 12:00 UTC
Sandoz Group AG (SDZNY) Q3 2026 Sales/Trading Call Transcript | Seeking Alpha
2.1% of QEFA
The Manila times · 28 Oct 2026, 11:10 UTC
Monte Rosa Therapeutics Announces Milestone Achievement Associated with Second Phase 2 Clinical Study Initiation for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)
2.1% of QEFA
The Wall Street Journal · 28 Oct 2026, 09:49 UTC
Sandoz Shares Fall After Company Turns Cautious on Sales Guidance
2.1% of QEFA
Investing.com · 28 Oct 2026, 09:35 UTC
Earnings call transcript: Sandoz narrows 2026 sales view after strong Q3 By Investing.com
2.1% of QEFA
Bloomberg Business · 28 Oct 2026, 09:34 UTC
Sandoz Warns EU May Scrap Antibiotic Protection, Risking Plant
2.1% of QEFA
Investing.com · 28 Oct 2026, 08:36 UTC
Why is Sandoz stock sliding today? By Investing.com
2.1% of QEFA
RTTNews · 28 Oct 2026, 07:56 UTC
Sandoz Q3 Sales Rise 4%; Cuts Annual Sales Growth Outlook, But Ups Profit Margin View
2.1% of QEFA
wallstreet:online · 28 Oct 2026, 12:05 UTC
AstraZeneca and Mark-Paul Gosselaar Launch Meet Your Mark to Raise Awareness of Cancer Biomarker Testing
1.9% of QEFA
Yahoo! Finance · 28 Oct 2026, 07:29 UTC
The Zacks Analyst Blog Highlights Eli Lilly, Novartis, Johnson & Johnson and AbbVie
2.1% of QEFA
The Manila times · 28 Oct 2026, 11:31 UTC
Micron Biomedical Appoints Anand Subramony, Ph.D., as Executive Vice President, Global Product Development and Combination Product Commercialization
1.9% of QEFA
Reuters · 28 Oct 2026, 06:52 UTC
Generic drugmaker Sandoz lowers sales outlook, lifts profit forecast
2.1% of QEFA
London South East · 28 Oct 2026, 11:23 UTC
WRAPUP 2-European banks beat profit forecasts, Brazil overshadows Santander
1.6% of QEFA
The Manila times · 28 Oct 2026, 06:07 UTC
Roche strengthens cancer diagnostic portfolio with launch of test for differential diagnosis of mesothelioma
1.8% of QEFA
wallstreet:online · 28 Oct 2026, 06:05 UTC
DKSH Expands its Healthcare Own Brands Portfolio With the Acquisition of Rocephin From Roche
1.8% of QEFA